⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
INMB News
INmune Bio Inc. Common stock
Form 8-K
sec.gov
INMB
INmune Bio, Inc. Announces Pricing of $4.50 Million Registered Direct Offering and Concurrent Private Placement
globenewswire.com
INMB
Form 8-K
sec.gov
INMB
INmune Bio Advances Ebstrocel™ Toward Potential UK Approval in Mid-2027
globenewswire.com
INMB
INmune Bio Establishes Global Commercialization Framework for Ebstrocel™ Through Strategic Agreement with Uniphar
globenewswire.com
INMB
INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer’s Drug Research and Explore New Applications for XPro ™
globenewswire.com
QUBT
INMB
INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer's Drug Research and Explore New Applications for XPro ™
prnewswire.com
QUBT
INMB
INmune Bio to Attend the 2026 Maxim Growth Summit
globenewswire.com
INMB
Form 8-K
sec.gov
INMB
INmune Bio Appoints Sanofi Rare-Disease Executive and Biopharma Business Development Leader to Board
globenewswire.com
INMB